European Leukemia Trial Registry
Trial: DELTA

More Details
Title Randomisierte Phase II Studie zu Decitabin/Azacitidin plus/minus Eltrombopag bei älteren Patienten mit AML
Scientific Title A randomized placebo-controlled phase 2 study of decitabine with or without eltrombopag in AML patients ≥65 years of age not eligible for intensive chemotherapy
Short Title DELTA
Trialgroup SAL
Type of Trial multicentric, randomized, prospective, double-blind, double-group
Disease Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age >= 65 years
Status Active
Start of Recruitment 18.06.2015
Leader Platzbecker, Prof. Dr. med., Uwe
Contactperson

Administrative needs
Helas, Dr., Susann
Tel: +49 (0)351 458 3089
Fax: +49 (0)351 458 4367
Email: susann.helas@uniklinikum-dresden.de

Centre of Trial Universitätsklinikum Carl Gustav Carus, Dresden
Shortprotocol Shortprotocol
created 13.10.2016 Student Studienregister
changed 13.10.2016 Sina Hehn
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org